Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review

ABSTRACT Deleterious effects of free fatty acids, FFAs, on insulin sensitivity are observed in vivo studies in humans. Mechanisms include impaired insulin signaling, oxidative stress, inflammation, and mitochondrial dysfunction, but the effects on insulin secretion are less well known. Our aim was to review the relationship of increased FFAs with insulin resistance, secretion and mainly with the incretin effect in humans. Narrative review. Increased endogenous or administered FFAs induce insulin resistance. FFAs effects on insulin secretion are debatable; inhibition and stimulation have been reported, depending on the type and duration of lipids exposition and the study subjects. Chronically elevated FFAs seem to decrease insulin biosynthesis, glucose-stimulated insulin secretion and β-cell glucose sensitivity. Lipids infusion decreases the response to incretins with unchanged incretin levels in volunteers with normal glucose tolerance. In contrast, FFAs reduction by acipimox did not restore the incretin effect in type-2 diabetes, probably due to the dysfunctional β-cell. Possible mechanisms of FFAs excess on incretin effect include reduction of the expression and levels of GLP-1 (glucagon like peptide-1) receptor, reduction of connexin-36 expression thus the coordinated secretory activity in response to GLP-1, and GIP (glucose-dependent insulinotropic polypeptide) receptors downregulation in islets cells. Increased circulating FFAs impair insulin sensitivity. Effects on insulin secretion are complex and controversial. Deleterious effects on the incretin-induced potentiation of insulin secretion were reported. More investigation is needed to better understand the extent and mechanisms of β-cell impairment and insulin resistance induced by increased FFAs and how to prevent them.

Saved in:
Bibliographic Details
Main Authors: Chueire,Valeria Bahdur, Muscelli,Elza
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100024
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972021000100024
record_format ojs
spelling oai:scielo:S2359-399720210001000242021-02-25Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative reviewChueire,Valeria BahdurMuscelli,Elza FFAs T2D insulin secretion incretin effect insulin sensitivity ABSTRACT Deleterious effects of free fatty acids, FFAs, on insulin sensitivity are observed in vivo studies in humans. Mechanisms include impaired insulin signaling, oxidative stress, inflammation, and mitochondrial dysfunction, but the effects on insulin secretion are less well known. Our aim was to review the relationship of increased FFAs with insulin resistance, secretion and mainly with the incretin effect in humans. Narrative review. Increased endogenous or administered FFAs induce insulin resistance. FFAs effects on insulin secretion are debatable; inhibition and stimulation have been reported, depending on the type and duration of lipids exposition and the study subjects. Chronically elevated FFAs seem to decrease insulin biosynthesis, glucose-stimulated insulin secretion and β-cell glucose sensitivity. Lipids infusion decreases the response to incretins with unchanged incretin levels in volunteers with normal glucose tolerance. In contrast, FFAs reduction by acipimox did not restore the incretin effect in type-2 diabetes, probably due to the dysfunctional β-cell. Possible mechanisms of FFAs excess on incretin effect include reduction of the expression and levels of GLP-1 (glucagon like peptide-1) receptor, reduction of connexin-36 expression thus the coordinated secretory activity in response to GLP-1, and GIP (glucose-dependent insulinotropic polypeptide) receptors downregulation in islets cells. Increased circulating FFAs impair insulin sensitivity. Effects on insulin secretion are complex and controversial. Deleterious effects on the incretin-induced potentiation of insulin secretion were reported. More investigation is needed to better understand the extent and mechanisms of β-cell impairment and insulin resistance induced by increased FFAs and how to prevent them.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.65 n.1 20212021-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100024en10.20945/2359-3997000000313
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Chueire,Valeria Bahdur
Muscelli,Elza
spellingShingle Chueire,Valeria Bahdur
Muscelli,Elza
Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
author_facet Chueire,Valeria Bahdur
Muscelli,Elza
author_sort Chueire,Valeria Bahdur
title Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
title_short Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
title_full Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
title_fullStr Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
title_full_unstemmed Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
title_sort effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
description ABSTRACT Deleterious effects of free fatty acids, FFAs, on insulin sensitivity are observed in vivo studies in humans. Mechanisms include impaired insulin signaling, oxidative stress, inflammation, and mitochondrial dysfunction, but the effects on insulin secretion are less well known. Our aim was to review the relationship of increased FFAs with insulin resistance, secretion and mainly with the incretin effect in humans. Narrative review. Increased endogenous or administered FFAs induce insulin resistance. FFAs effects on insulin secretion are debatable; inhibition and stimulation have been reported, depending on the type and duration of lipids exposition and the study subjects. Chronically elevated FFAs seem to decrease insulin biosynthesis, glucose-stimulated insulin secretion and β-cell glucose sensitivity. Lipids infusion decreases the response to incretins with unchanged incretin levels in volunteers with normal glucose tolerance. In contrast, FFAs reduction by acipimox did not restore the incretin effect in type-2 diabetes, probably due to the dysfunctional β-cell. Possible mechanisms of FFAs excess on incretin effect include reduction of the expression and levels of GLP-1 (glucagon like peptide-1) receptor, reduction of connexin-36 expression thus the coordinated secretory activity in response to GLP-1, and GIP (glucose-dependent insulinotropic polypeptide) receptors downregulation in islets cells. Increased circulating FFAs impair insulin sensitivity. Effects on insulin secretion are complex and controversial. Deleterious effects on the incretin-induced potentiation of insulin secretion were reported. More investigation is needed to better understand the extent and mechanisms of β-cell impairment and insulin resistance induced by increased FFAs and how to prevent them.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000100024
work_keys_str_mv AT chueirevaleriabahdur effectoffreefattyacidsoninsulinsecretioninsulinsensitivityandincretineffectanarrativereview
AT muscellielza effectoffreefattyacidsoninsulinsecretioninsulinsensitivityandincretineffectanarrativereview
_version_ 1756441449715466240